Regarding Bicluster 3, the high use of tocilizumab is interesting (Figure 14, bottom left), which is a humanized monoclonal antibody against the Interleukin-6 Receptor (IL-6R), which is used for Cytokine Release Syndrome (CRS). The gene discussed is IL6R; the disease is congenital rubella syndrome.